Saturday, June 4, 2016

BRIEF-Merck KGaA partners with Array BioPharma, Pierre Fabre on mCRC phase iii trial

* Says partners with Array BioPharma and Pierre Fabre to

initiate braf-mutant mCRC phase iii trial

Further company coverage:

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)